The expression profile of NEK2 was analyzed by Takahashi et al. in patients with CRC who underwent surgical treatment [38], demonstrating that the high NEK2 expression group had significantly greater peritoneal dissemination compared to the low expression group. This evidence concerns the gene NEK2 and colorectal carcinoma.